Impact of hepatitis B virus rtA181V/T mutants on hepatitis B treatment failure☆
To access this article, please choose from the options below
☆ The authors declare that they do not have anything to disclose regarding conflict of interest with respect to this manuscript except Drs. Barraud and Durantel who are Bioalliance Pharma employees, France.
PII: S0168-8278(08)00120-7
doi:10.1016/j.jhep.2008.01.027
© 2008 European Association for the Study of the Liver. Published by Elsevier Inc. All rights reserved.
